Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia. | Nat Commun | 2021 | 34112805 | PubTator, text mining | PubMed |
| BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia. | Curr Treat Options Oncol | 2021 | 34110507 | PubTator, text mining | PubMed |
| Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome In Vitro by Pharmacological Inhibition of Cdc42-Induced Actin Cytoskeleton Remodeling. | Front Immunol | 2021 | 34108958 | PubTator, text mining | PubMed |
| Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy. | Antib Ther | 2021 | 34104872 | PubTator, text mining | PubMed |
| Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. | Nature | 2021 | 34098567 | PubTator, text mining | PubMed |
| Label-free quantitative proteomic analysis of serum extracellular vesicles differentiating patients of alcoholic and nonalcoholic fatty liver diseases. | J Proteomics | 2021 | 34089894 | PubTator, text mining | PubMed |
| Exploring the pathways to chronic lymphocytic leukemia. | Blood | 2021 | 34075408 | PubTator, text mining | PubMed |
| Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines. | ACS Cent Sci | 2021 | 34075345 | PubTator, text mining | PubMed |
| Review of Venetoclax in CLL, AML and Multiple Myeloma. | J Pers Med | 2021 | 34073976 | PubTator, text mining | PubMed |
| Current State of CAR T-Cell Therapy in Chronic Lymphocytic Leukemia. | Int J Mol Sci | 2021 | 34073911 | PubTator, text mining | PubMed |
| Current Treatment Options in CLL. | Cancers (Basel) | 2021 | 34069354 | PubTator, text mining | PubMed |
| The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment. | Diagnostics (Basel) | 2021 | 34068813 | PubTator, text mining | PubMed |
| The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia. | J Clin Med | 2021 | 34065833 | PubTator, text mining | PubMed |
| Physiological Fitness and the Pathophysiology of Chronic Lymphocytic Leukemia (CLL). | Cells | 2021 | 34064804 | PubTator, text mining | PubMed |
| The Impact of Chlorambucil and Valproic Acid on Cell Viability, Apoptosis and Expression of p21, HDM2, BCL2 and MCL1 Genes in Chronic Lymphocytic Leukemia. | Cells | 2021 | 34063233 | PubTator, text mining | PubMed |
| Reliable IGHV status assessment by next generation sequencing in routine practice for chronic lymphocytic leukemia. | Leuk Lymphoma | 2021 | 34060965 | PubTator, text mining | PubMed |
| Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction. | Amino Acids | 2021 | 34059947 | PubTator, text mining | PubMed |
| Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine. | ACS Cent Sci | 2021 | 34056089 | PubTator, text mining | PubMed |
| Acalabrutinib: A Selective Bruton Tyrosine Kinase Inhibitor for the Treatment of B-Cell Malignancies. | Front Oncol | 2021 | 34055635 | PubTator, text mining | PubMed |
| Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells. | Front Oncol | 2021 | 34055615 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=45